DK236185A - Stabiliseret insulin-formulering - Google Patents
Stabiliseret insulin-formulering Download PDFInfo
- Publication number
- DK236185A DK236185A DK236185A DK236185A DK236185A DK 236185 A DK236185 A DK 236185A DK 236185 A DK236185 A DK 236185A DK 236185 A DK236185 A DK 236185A DK 236185 A DK236185 A DK 236185A
- Authority
- DK
- Denmark
- Prior art keywords
- insulin formulation
- stabilized insulin
- stabilized
- formulation
- insulin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61435584A | 1984-05-29 | 1984-05-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK236185D0 DK236185D0 (da) | 1985-05-28 |
DK236185A true DK236185A (da) | 1985-11-30 |
Family
ID=24460897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK236185A DK236185A (da) | 1984-05-29 | 1985-05-28 | Stabiliseret insulin-formulering |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0166529B1 (fr) |
JP (1) | JPS6122026A (fr) |
CA (1) | CA1244347A (fr) |
DE (1) | DE3576458D1 (fr) |
DK (1) | DK236185A (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0018609B1 (fr) * | 1979-04-30 | 1983-09-21 | Hoechst Aktiengesellschaft | Solutions aqueuses de protéines, stables à la dénaturation, procédé pour leur fabrication et leur utilisation |
IL78425A (en) * | 1985-04-15 | 1991-05-12 | Lilly Co Eli | Intranasal formulation containing insulin |
IL79552A0 (en) * | 1985-07-30 | 1986-10-31 | Int Minerals & Chem Corp | Stabilization of growth promoting hormones |
AU2455295A (en) * | 1994-05-20 | 1995-12-18 | Hisamitsu Pharmaceutical Co., Inc. | Protein or polypeptide, process for producing the same, and intermediate compound tehrefor |
US5968899A (en) * | 1994-06-03 | 1999-10-19 | Tsumura & Co. | Medicinal compositions of peptides with EACA or tranexamic acid for enhanced mucosal absorption |
FR2755440B1 (fr) * | 1996-11-07 | 1999-01-15 | Tuffet Sophie | Procede de conservation de longue duree de molecules d'adn et conditionnement pour sa mise en oeuvre |
ES2248902T3 (es) * | 1998-05-06 | 2006-03-16 | Societe Imagene | Procedimiento de conservacion de larga duracion de moleculas de adn y envase para su realizacion. |
DE10114178A1 (de) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität |
DE10227232A1 (de) | 2002-06-18 | 2004-01-15 | Aventis Pharma Deutschland Gmbh | Saure Insulinzubereitungen mit verbesserter Stabilität |
LT2349324T (lt) | 2008-10-17 | 2017-12-27 | Sanofi-Aventis Deutschland Gmbh | Insulino ir glp-1 agonisto derinys |
PL2498801T3 (pl) | 2009-11-13 | 2018-08-31 | Sanofi Aventis Deutschland | Kompozycja farmaceutyczna zawierająca desPro<sup>36</sup>eksendyno-4(1-39)-Lys6-NH2 i metioninę |
ES2534191T3 (es) | 2009-11-13 | 2015-04-20 | Sanofi-Aventis Deutschland Gmbh | Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina |
HUE031181T2 (en) | 2010-08-30 | 2017-06-28 | Sanofi Aventis Deutschland | Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
CN108079281A (zh) | 2011-08-29 | 2018-05-29 | 赛诺菲-安万特德国有限公司 | 用于2型糖尿病患者中的血糖控制的药物组合 |
AR087744A1 (es) | 2011-09-01 | 2014-04-16 | Sanofi Aventis Deutschland | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa |
US9950039B2 (en) | 2014-12-12 | 2018-04-24 | Sanofi-Aventis Deutschland Gmbh | Insulin glargine/lixisenatide fixed ratio formulation |
TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0018609B1 (fr) * | 1979-04-30 | 1983-09-21 | Hoechst Aktiengesellschaft | Solutions aqueuses de protéines, stables à la dénaturation, procédé pour leur fabrication et leur utilisation |
ZA808097B (en) * | 1980-12-29 | 1982-01-27 | Lilly Co Eli | Novel insulin formulations |
-
1985
- 1985-05-27 CA CA000482422A patent/CA1244347A/fr not_active Expired
- 1985-05-28 EP EP19850303721 patent/EP0166529B1/fr not_active Expired
- 1985-05-28 DK DK236185A patent/DK236185A/da not_active Application Discontinuation
- 1985-05-28 JP JP60115174A patent/JPS6122026A/ja active Pending
- 1985-05-28 DE DE8585303721T patent/DE3576458D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK236185D0 (da) | 1985-05-28 |
JPS6122026A (ja) | 1986-01-30 |
EP0166529A1 (fr) | 1986-01-02 |
DE3576458D1 (de) | 1990-04-19 |
CA1244347A (fr) | 1988-11-08 |
EP0166529B1 (fr) | 1990-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR8806982A (pt) | Composicao estabilizada | |
BR8802017A (pt) | Composicao estabilizada | |
NO2000005I1 (no) | Insulin aspart | |
DK481585A (da) | Farmaceutisk praeparat indeholdende anthracyclinglycosider | |
MX163529B (es) | Composicion quimicoluminiscente | |
DK479685A (da) | Stol | |
DK236185D0 (da) | Stabiliseret insulin-formulering | |
DK162562C (da) | Staldkonstruktion | |
IT1209615B (it) | Composizione farmaceutica | |
DK437786D0 (da) | Insulinprecursorer | |
DK86785D0 (da) | Bromcryptinpraeparater | |
DK182287D0 (da) | Stabiliserede peptidsoedemidler | |
FR2582908B3 (fr) | Compositions stabilisees. | |
ES288629Y (es) | Jeringa | |
DK51885D0 (da) | Glycosylerede insulinderivater | |
KR860007343U (ko) | 주사용 수액세트 | |
MX163537B (es) | Composicion insecticida | |
ES276839Y (es) | Jeringuilla | |
BR8406387A (pt) | Seringa | |
SE8402858D0 (sv) | Ampull | |
SE8400444D0 (sv) | Ateranvendningsbart bodunderlag | |
DK42483D0 (da) | Stabiliserede insulinoploesninger | |
RO90654A2 (fr) | Composition insecticide sinergique | |
RO92144A2 (fr) | Composition insecticide | |
LT2605B (lt) | Insekticidinis preparatas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ATS | Application withdrawn |